ロード中...
Expression of Programmed Death-Ligand 1 and Programmed Death-1 in Patients with Extramammary Paget's Disease
BACKGROUND: Extramammary Paget's disease (EMPD) is a rare skin cancer and sometimes has fatal prognosis. For progressive cases, therapeutic options are limited. In recent years, treatment with an anti-programmed death-1 (PD-1) antibody has improved the prognosis of various malignancies. In addi...
保存先:
| 出版年: | Indian J Dermatol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wolters Kluwer - Medknow
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8208280/ https://ncbi.nlm.nih.gov/pubmed/34188273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijd.IJD_341_18 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|